| Multiple Sclerosis |
1 |
1 |
| Artificial Intelligence |
0 |
0.39 |
| Biomarker |
0 |
0.39 |
| Brain |
0 |
0.39 |
| Demyelination |
0 |
0.39 |
| Adverse Effects |
0 |
0.2 |
| Blood |
0 |
0.2 |
| Cerebrovascular Disease |
0 |
0.2 |
| Immunoglobulin G (IgG) |
0 |
0.2 |
| Magnetic Resonance Imaging |
0 |
0.2 |
| Multiple Sclerosis Relapse |
0 |
0.2 |
| Multiple Sclerosis Treatment |
0 |
0.2 |
| Myelin |
0 |
0.2 |
| Neuromyelitis Optica |
0 |
0.2 |
| Referral |
0 |
0.2 |
| Spinal Cord |
0 |
0.2 |
| Vein |
0 |
0.2 |
| Healthcare and Medical Technology |
0 |
0.08 |